Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Recruiting 13Completed 9Terminated 5Unknown 4Active not recruiting 4Withdrawn 3Not yet recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 41Thoracic 17Head & Neck 8Lymphoid 4Tumor-Agnostic 3Genitourinary 3Other solid neoplasm 2Gynecologic 2CNS 2Breast 1

Conditions

MSI-H Colorectal Cancer 1Advanced Solid Tumor 1

Interventions

Injections 9Interviews as Topic 5Carboplatin 5Cisplatin 4toripalimab 3fludarabine 3Pemetrexed 3Iodine-125 3Immune Checkpoint Inhibitors 3Fluorodeoxyglucose F18 3tislelizumab 2envafolimab 2Specimen Handling 2Paclitaxel 2Oxaliplatin 2Drug Therapy 2Cyclophosphamide 2Cryosurgery 2Capecitabine 2Blood Specimen Collection 2trastuzumab deruxtecan 1spartalizumab 1somatostatin receptor 2 1sintilimab 1regorafenib 1pembrolizumab 1osimertinib 1olaparib 1nabiximols 1malic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × tislelizumab × Other solid neoplasm × Clear all
NCT07396090 2026-02-09

Study of KRAS-Specific Vaccine in Patients With KRAS-Mutated Solid Tumors

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase NA Not yet recruiting
13 enrolled
Other solid neoplasm

Advanced Solid Tumor

NCT05841134 2023-05-09

Tislelizumab Combined With Chemotherapy (CAPOX) in the Perioperative Treatment of MSI-H/dMMR Stage II or III Colorectal Cancer

The First Affiliated Hospital of Zhengzhou University

Phase 2 Not yet recruiting
25 enrolled
GastrointestinalOther solid neoplasm

MSI-H Colorectal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡